The results of these studies are conflicting, three studies suggested that maspin underexpression could be a potential poor prognostic marker in breast cancer, while the fourth identified maspin overexpression rather as an independent poor prognostic indicator in breast cancer patients (Umerika et al, 2002). The gene discussed is SERPINB5; the disease is breast carcinoma.